Filing Details

Accession Number:
0000899243-19-023735
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-09-17 16:21:02
Reporting Period:
2019-09-13
Accepted Time:
2019-09-17 16:21:02
Original Submission Date:
2019-09-17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1341235 Aldeyra Therapeutics Inc. ALDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1579179 C Todd Brady C/O Aldeyra Therapeutics, Inc.
131 Hartwell Avenue
Lexington MA 02421
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-13 18,547 $5.90 597,538 No 4 P Direct
Common Stock Acquisiton 2019-09-16 3,000 $6.03 600,538 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Includes 8,547 shares that were inadvertently omitted from the original Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.79 to $6.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4.